Genelabs, Taiwan National Health Research Institutes and Genovate To Co-Develop New Hepatitis C Treatment

SHANGHAI - Genelabs Technologies inked a development agreement with the Taiwan National Health Research Institutes and Genovate Biotechnology to co-develop drugs to treat hepatitis C, the company announced July 23